Showing results (551-560 of 1,724) with videos related to
Sort By:
Pageof 173
CNS Spectrums|July 8, 2017
Beyond the pill: new medication delivery options for ADHDAndrew J Cutler, Gregory W MattinglyCNS Spectrums|April 21, 2018
Antagonist treatment is just as effective as replacement therapy for opioid addiction but neither is used often enoughStephen M StahlCNS Spectrums|June 6, 2018
Pharmacotherapy of schizophrenia: toward a metabolomic-based approachHaythum O Tayeb, Hussam A Murad, Misbahuddin M Rafeeq, et al.CNS Spectrums|June 6, 2018
Factors associated with poor satisfaction with treatment and trial discontinuation in chronic schizophreniaJoep H Schoemaker, Ad J J M Vingerhoets, Robin A EmsleyCNS Spectrums|June 27, 2018
Switching stable patients with schizophrenia from their oral antipsychotics to aripiprazole lauroxil: a post hoc safety analysis of the initial 12-week crossover periodPeter J Weiden, Yangchun Du, Chih-Chin Liu, et al.CNS Spectrums|June 7, 2019
Cold pressor pain and gambling disorder: implications for the opioid systemJon E Grant, Samuel R ChamberlainCNS Spectrums|May 24, 2019
Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetineJean Lachaine, Catherine Beauchemin, Joëlle Bibeau, et al.CNS Spectrums|May 28, 2019
Neurocognitive heterogeneity across the spectrum of psychopathology: need for improved approaches to deficit detection and interventionBrian C Kavanaugh, Mary Kathryn Cancilliere, Anthony SpiritoCNS Spectrums|September 28, 2018
Odor sensitivity impairment: a behavioral marker of psychological distress?David C Houghton, Samuel L Howard, Thomas W Uhde, et al.CNS Spectrums|October 3, 2019
A longitudinal description of incompetent to stand trial admissions to a state hospitalBarbara E McDermott, Katherine Warburton, Chloe Auletta-YoungPageof 173